Investing.com - Benitec Biopharma ADR reported on Wednesday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Benitec Biopharma ADR announced earnings per share of -0.76 on revenue of 1.00K. Analysts polled by Investing.com anticipated EPS of -0.75 on revenue of 35K.
Benitec Biopharma ADR shares are down 2% from the beginning of the year and are trading at 4.95 , down-from-52-week-high.They are under-performing the IBEX 35 which is down 0.23% from the start of the year.
Benitec Biopharma ADR follows other major Healthcare sector earnings this month
Benitec Biopharma ADR's report follows an earnings beat by J&J on Tuesday, January 26, 2021, who reported EPS of 1.86 on revenue of 22.48B, compared to forecasts EPS of 1.82 on revenue of 21.66B.
Roche Holding ADR had missed expectations on Monday, February 1, 2021 with fourth quarter EPS of 1.21 on revenue of 15.88B, compared to forecast for EPS of 1.28 on revenue of 16.45B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar